Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer: data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
5 January 2021
|
| In: |
The breast
Year: 2021, Jahrgang: 55, Pages: 138-139 |
| ISSN: | 1532-3080 |
| DOI: | 10.1016/j.breast.2020.12.007 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.breast.2020.12.007 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0960977620302472 
|
| Verfasserangaben: | Andreas Schneeweiss, Johannes Ettl, Diana Lüftner, Matthias W. Beckmann, Erik Belleville, Peter A. Fasching, Tanja N. Fehm, Matthias Geberth, Lothar Häberle, Peyman Hadji, Andreas D. Hartkopf, Carsten Hielscher, Jens Huober, Eugen Ruckhäberle, Wolfgang Janni, Hans Christian Kolberg, Christian M. Kurbacher, Evelyn Klein, Michael P. Lux, Volkmar Müller, Naiba Nabieva, Friedrich Overkamp, Hans Tesch, Elena Laakmann, Florin-Andrei Taran, Julia Seitz, Christoph Thomssen, Michael Untch, Pauline Wimberger, Rachel Wuerstlein, Bernhard Volz, Diethelm Wallwiener, Markus Wallwiener, Sara Y. Brucker |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 175365548X | ||
| 003 | DE-627 | ||
| 005 | 20230426175730.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210412s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.breast.2020.12.007 |2 doi | |
| 035 | |a (DE-627)175365548X | ||
| 035 | |a (DE-599)KXP175365548X | ||
| 035 | |a (OCoLC)1341403911 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schneeweiss, Andreas |d 1961- |e VerfasserIn |0 (DE-588)109972554 |0 (DE-627)632849630 |0 (DE-576)327251859 |4 aut | |
| 245 | 1 | 0 | |a Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer |b data from the PRAEGNANT research network for the first 2 years of drug availability in Germany" |c Andreas Schneeweiss, Johannes Ettl, Diana Lüftner, Matthias W. Beckmann, Erik Belleville, Peter A. Fasching, Tanja N. Fehm, Matthias Geberth, Lothar Häberle, Peyman Hadji, Andreas D. Hartkopf, Carsten Hielscher, Jens Huober, Eugen Ruckhäberle, Wolfgang Janni, Hans Christian Kolberg, Christian M. Kurbacher, Evelyn Klein, Michael P. Lux, Volkmar Müller, Naiba Nabieva, Friedrich Overkamp, Hans Tesch, Elena Laakmann, Florin-Andrei Taran, Julia Seitz, Christoph Thomssen, Michael Untch, Pauline Wimberger, Rachel Wuerstlein, Bernhard Volz, Diethelm Wallwiener, Markus Wallwiener, Sara Y. Brucker |
| 246 | 3 | 0 | |a four six two |
| 264 | 1 | |c 5 January 2021 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 12.04.2021 | ||
| 700 | 1 | |a Ettl, Johannes |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lüftner, Diana |e VerfasserIn |4 aut | |
| 700 | 1 | |a Beckmann, Matthias W. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Belleville, Erik |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fasching, Peter A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fehm, Tanja N. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Geberth, Matthias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Häberle, Lothar |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hadji, Peyman |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hartkopf, Andreas D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hielscher, Carsten |e VerfasserIn |4 aut | |
| 700 | 1 | |a Huober, Jens |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ruckhäberle, Eugen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Janni, Wolfgang |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kolberg, Hans Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kurbacher, Christian M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Klein, Evelyn |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lux, Michael P. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Müller, Volkmar |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nabieva, Naiba |e VerfasserIn |4 aut | |
| 700 | 1 | |a Overkamp, Friedrich |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tesch, Hans |e VerfasserIn |4 aut | |
| 700 | 1 | |a Laakmann, Elena |e VerfasserIn |4 aut | |
| 700 | 1 | |a Taran, Florin-Andrei |e VerfasserIn |4 aut | |
| 700 | 1 | |a Seitz, Julia |d 1981- |e VerfasserIn |0 (DE-588)1127256173 |0 (DE-627)88170623X |0 (DE-576)485156679 |4 aut | |
| 700 | 1 | |a Thomssen, Christoph |e VerfasserIn |4 aut | |
| 700 | 1 | |a Untch, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wimberger, Pauline |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wuerstlein, Rachel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Volz, Bernhard |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wallwiener, Diethelm |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wallwiener, Markus |d 1980- |e VerfasserIn |0 (DE-588)134044827 |0 (DE-627)692043934 |0 (DE-576)27468327X |4 aut | |
| 700 | 1 | |a Brucker, Sara Y. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The breast |d Amsterdam [u.a.] : Elsevier, 1992 |g 55(2021), Seite 138-139 |h Online-Ressource |w (DE-627)320475042 |w (DE-600)2009043-2 |w (DE-576)103868151 |x 1532-3080 |7 nnas |a Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer data from the PRAEGNANT research network for the first 2 years of drug availability in Germany" |
| 773 | 1 | 8 | |g volume:55 |g year:2021 |g pages:138-139 |g extent:2 |a Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer data from the PRAEGNANT research network for the first 2 years of drug availability in Germany" |
| 787 | 0 | 8 | |i Errata zu |a Schneeweiss, Andreas, 1961 - |t Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer |d 2020 |w (DE-627)1748263293 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.breast.2020.12.007 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0960977620302472 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210412 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 134044827 |a Wallwiener, Markus |m 134044827:Wallwiener, Markus |d 910000 |d 910400 |d 50000 |e 910000PW134044827 |e 910400PW134044827 |e 50000PW134044827 |k 0/910000/ |k 1/910000/910400/ |k 0/50000/ |p 33 | ||
| 998 | |g 1127256173 |a Seitz, Julia |m 1127256173:Seitz, Julia |p 26 | ||
| 998 | |g 109972554 |a Schneeweiss, Andreas |m 109972554:Schneeweiss, Andreas |d 910000 |d 910400 |d 50000 |e 910000PS109972554 |e 910400PS109972554 |e 50000PS109972554 |k 0/910000/ |k 1/910000/910400/ |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN175365548X |e 3906191842 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"display":"Schneeweiss, Andreas","given":"Andreas","family":"Schneeweiss","role":"aut"},{"display":"Ettl, Johannes","given":"Johannes","role":"aut","family":"Ettl"},{"display":"Lüftner, Diana","given":"Diana","role":"aut","family":"Lüftner"},{"given":"Matthias W.","display":"Beckmann, Matthias W.","family":"Beckmann","role":"aut"},{"family":"Belleville","role":"aut","display":"Belleville, Erik","given":"Erik"},{"role":"aut","family":"Fasching","given":"Peter A.","display":"Fasching, Peter A."},{"display":"Fehm, Tanja N.","given":"Tanja N.","role":"aut","family":"Fehm"},{"family":"Geberth","role":"aut","display":"Geberth, Matthias","given":"Matthias"},{"family":"Häberle","role":"aut","display":"Häberle, Lothar","given":"Lothar"},{"family":"Hadji","role":"aut","given":"Peyman","display":"Hadji, Peyman"},{"given":"Andreas D.","display":"Hartkopf, Andreas D.","family":"Hartkopf","role":"aut"},{"given":"Carsten","display":"Hielscher, Carsten","family":"Hielscher","role":"aut"},{"family":"Huober","role":"aut","given":"Jens","display":"Huober, Jens"},{"role":"aut","family":"Ruckhäberle","given":"Eugen","display":"Ruckhäberle, Eugen"},{"family":"Janni","role":"aut","given":"Wolfgang","display":"Janni, Wolfgang"},{"family":"Kolberg","role":"aut","display":"Kolberg, Hans Christian","given":"Hans Christian"},{"family":"Kurbacher","role":"aut","display":"Kurbacher, Christian M.","given":"Christian M."},{"display":"Klein, Evelyn","given":"Evelyn","role":"aut","family":"Klein"},{"role":"aut","family":"Lux","display":"Lux, Michael P.","given":"Michael P."},{"role":"aut","family":"Müller","given":"Volkmar","display":"Müller, Volkmar"},{"given":"Naiba","display":"Nabieva, Naiba","family":"Nabieva","role":"aut"},{"display":"Overkamp, Friedrich","given":"Friedrich","family":"Overkamp","role":"aut"},{"display":"Tesch, Hans","given":"Hans","role":"aut","family":"Tesch"},{"family":"Laakmann","role":"aut","given":"Elena","display":"Laakmann, Elena"},{"display":"Taran, Florin-Andrei","given":"Florin-Andrei","family":"Taran","role":"aut"},{"role":"aut","family":"Seitz","given":"Julia","display":"Seitz, Julia"},{"display":"Thomssen, Christoph","given":"Christoph","family":"Thomssen","role":"aut"},{"given":"Michael","display":"Untch, Michael","family":"Untch","role":"aut"},{"role":"aut","family":"Wimberger","given":"Pauline","display":"Wimberger, Pauline"},{"role":"aut","family":"Wuerstlein","given":"Rachel","display":"Wuerstlein, Rachel"},{"display":"Volz, Bernhard","given":"Bernhard","family":"Volz","role":"aut"},{"role":"aut","family":"Wallwiener","display":"Wallwiener, Diethelm","given":"Diethelm"},{"role":"aut","family":"Wallwiener","display":"Wallwiener, Markus","given":"Markus"},{"family":"Brucker","role":"aut","given":"Sara Y.","display":"Brucker, Sara Y."}],"recId":"175365548X","note":["Gesehen am 12.04.2021"],"language":["eng"],"name":{"displayForm":["Andreas Schneeweiss, Johannes Ettl, Diana Lüftner, Matthias W. Beckmann, Erik Belleville, Peter A. Fasching, Tanja N. Fehm, Matthias Geberth, Lothar Häberle, Peyman Hadji, Andreas D. Hartkopf, Carsten Hielscher, Jens Huober, Eugen Ruckhäberle, Wolfgang Janni, Hans Christian Kolberg, Christian M. Kurbacher, Evelyn Klein, Michael P. Lux, Volkmar Müller, Naiba Nabieva, Friedrich Overkamp, Hans Tesch, Elena Laakmann, Florin-Andrei Taran, Julia Seitz, Christoph Thomssen, Michael Untch, Pauline Wimberger, Rachel Wuerstlein, Bernhard Volz, Diethelm Wallwiener, Markus Wallwiener, Sara Y. Brucker"]},"relHost":[{"recId":"320475042","title":[{"title":"The breast","title_sort":"breast"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2009043-2"],"eki":["320475042"],"issn":["1532-3080"]},"origin":[{"dateIssuedKey":"1992","publisherPlace":"Amsterdam [u.a.] ; Burlington, Mass.","publisher":"Elsevier ; Harcourt","dateIssuedDisp":"1992-"}],"language":["eng"],"part":{"pages":"138-139","extent":"2","text":"55(2021), Seite 138-139","year":"2021","volume":"55"},"note":["Gesehen am 27.04.2020","Fortsetzung der Druck-Ausgabe"],"pubHistory":["1.1992 -"],"disp":"Corrigendum to \"Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer data from the PRAEGNANT research network for the first 2 years of drug availability in Germany\"The breast","type":{"bibl":"periodical","media":"Online-Ressource"}}],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"5 January 2021"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"Corrigendum to \"Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer","title":"Corrigendum to \"Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer","subtitle":"data from the PRAEGNANT research network for the first 2 years of drug availability in Germany\""}],"physDesc":[{"extent":"2 S."}],"id":{"doi":["10.1016/j.breast.2020.12.007"],"eki":["175365548X"]}} | ||
| SRT | |a SCHNEEWEISCORRIGENDU5202 | ||